Pharmaceuticals Businesses for Sale and Investment Opportunities

- Pharma manufacturing company, located in Nashik. - The plant is in its final stage of commissioning and will focus on the production of small volume parenterals in ampules, vials, PFS, and lyophilized products. - Technical inspection is pending, post which the business can obtain drug manufacturing license to start the manufacturing process. - Will be manufactured on a principle-to-principle and loan license basis for both local and export markets. - The product line includes human injectable products falling under drug categories such as antibiotics, steroids, analgesics etc. - Business model involves manufacturing products under the brand and formulation of other major pharmaceutical companies and supplying them for marketing and distribution. - The business is registered with the Ministry of Corporate Affairs (MCA), holds a Permanent Account Number (PAN), and is registered with the Micro, Small, and Medium Enterprises (MSME).

- We work with 50+ pharma companies for the distribution of their products. Abbott, Alcon, Emcure, Novartis, Pfizer, and Sun Pharma are some of the leading healthcare companies that we work with. - We deal with approximately 5,000 SKUs. - Our sales have increased significantly since our clientele has increased. - The funds will be utilized to invest in technological enablement, stocks and expand the customer base in Delhi NCR and Bangalore followed by other metro cities. - We are also planning to invest some funds into Medicine retail, which will significantly improve the bottom line. - With the investment, the company can grow beyond 20-30% YoY. - Exit will be given to the investors in 4-6 years with 18-21% annual IRR commitments. - The investors may co-invest with the other investors.

- API manufacturing unit in Telangana operational for the last 4 years. - This is a USFDA and EU regulation-compliant manufacturing facility. - The factory is used for contract manufacturing of APIs. - The buyer gets all the tangible and intangible assets of the factory.

- One roof solution for all kinds of production lines in the nutraceutical industry. - Factory is operational for job work and own brand manufacturing. - Facility with revenue potential of INR 100+ Crs. - Have a 5-6 tie-up. They are pharmacies, pharma marketing companies, etc. - Promoter has 8 years of experience in this industry. - It is a GMP and USFDA-approved company.

- We manufacture sleep-enhancing drinks. - The drink is manufactured on an OEM basis through our contract manufacturers. - Product is available across 600+ retail outlets in Malaysia including popular convenience chain stores and pharmacies. - Ready to sell in Singapore with required permits acquired. - Being a finalist of the FoodBev award in 2022 for most innovative functional beverage. - Formulated by proprietary formula with natural ingredients. - Planning to launch a series of branding and marketing strategies to boost brand awareness and offline product activation. - Have read offline channels to increase the physical selling spots of products. - Have the formula of new products ready for production and go-to-market. - The promoter has 2 years of experience in this industry and has previously been involved in the eCommerce and supply chain industry. - The business has a local authority certificate, factory certificate, and HACCP compliance certificate. - The business is currently operating at a loss as the business is still in the startup phase.

- We are a pharmaceuticals business located in Kolkata. - We have 5 own brands under the company. - The medicines are manufactured by a third-party manufacturer. - We are marketing these brands through franchise partners. - Business also operates two pharmacy retail stores where the medicines are offered at a 20% discount. - The products are marketed in North-East and East India. - Both verticals generate an equal amount of revenue. - The medicines are sold to 20-22 distributors while both pharmacies have a combined daily footfall of 450-500 customers. - Promoter has 35+ years of experience in the industry. - We are not a USFDA-approved company. - The business has GST, MSME, drug and trade licenses.

• Company is a 15 year old company with consistent performance over the years. • It started as a joint venture with a Dutch research company in the business of developing CO2 technology. The joint venture partners had a financial stake in the company. In March 2019 the Indian promoters bought the stake of the joint venture partners. It is now totally owned by the Indian promoters. • It has no debt totally self-funded. • Has a small team of dedicated workers. • No labour union. • Facility is a compact and modern state of the art. • Has a loyal base of customers both domestic and export. • Has a strong base of reliable suppliers. • Has an enviable market reputation as a reliable and proven supplier. • Company has a strong brand image. • Future growth opportunity is limited to capacity only. • In 15 years, it only had one bad debt. • There has been no rejection over the years. • Senior management slots can be filed without causing any resentment at the plant level. • The business is only expected to grow as regulations & legislation get stringent. • Extraction plants are in excellent condition, the heart of the machines has been developed indigenously and plant life is almost infinite at minimal expense. • The current promoters are willing to handhold for a year to ensure further growth and success of the company. • There are 2-3 new business opportunities that are being explored for rapid growth. • One major customer is in the process of converting more of its raw materials from steam to CO2 extracts. It has immense opportunity. • The manpower is well-trained in production & routine maintenance of the plant. • There are no cash transactions, and the company is in compliance with all statuary payments and regulations. • It has all required certifications in place such as ISO, halal, and organic certificate. • Reasonable market value of fixed assets. • We have 30 to 40 clients, who are all B2B clients. • Clients are from the food industry, Cosmetic, Aromatic and therapeutic industries. • We have 4 to 5 employees on a contract basis apart from permanent employees. • Our average annual revenue is INR 7 crore but last year we had Extraordinary sales due to new clients. • Company is registered in New Delhi but operations are in Rajasthan.

- Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management. - The brand, licenses, registrations, client base, and property have been transferred to the new owners. - Was supplying across Bangladesh, the Middle East, and African countries under its own branding. - The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production. - With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution. - The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs. - Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc. - The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets. - Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success. - The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization. - Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand. - Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.

- Business owner of a drug wholesale business planning to establish a pharmaceutical drug manufacturing plant. - The focus will be on creating a portfolio of drugs under the company's own brand name. - Initially, the manufacturing will concentrate on oral tablets and capsules, with future plans for expansion into other drug categories. - The company aims to supply its products to distributors across West Bengal, Jharkhand, Bihar, and Odisha. - Raw materials for the manufacturing process will be sourced from Ahmedabad and Visakhapatnam. - Will be obtaining drug license and FDA approval once the business launches.

- Non-operational business for 4 years. It has been non-operation since Covid times. - Our clients were mostly from South India, Ernakulam, Karnataka, Tamil Nadu, Orissa etc. - The promoter has 10 years of experience in this industry. - All the ITR filing is in place.